Prostate Cell News Volume 14.01 | Jan 13 2023

    0
    20








    2023-01-13 | PCN 14.01


    Prostate Cell News by STEMCELL Technologies
    Vol. 14.01 – 13 January, 2023
    TOP STORY

    SETDB1 Modulates Degradation of Phosphorylated RB and Anti-Cancer Efficacy of CDK4/6 Inhibitors

    Investigators demonstrated that RING finger domain protein TRIM28 bound and promoted ubiquitination and degradation of CDK4/6-phosphorylated retinoblastoma protein (RB).
    [Cancer Research]

    Abstract
    ON1104SM-Small-Molecules-Wallchart-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth

    In a subset of prostate cancer organoid culture and xenograft models, inhibition of Wnt synthesis stimulated growth, while WNT5a or a WNT5a mimetic peptide markedly suppressed tumor growth.
    [Cancer Research]

    Abstract

    Chaperone-Mediated Autophagy Promotes PCa Survival during ARPI through Selective Proteome Remodeling

    Scientists identified the up-regulation of chaperone-mediated autophagy in response to acute androgen receptor pathway inhibition (ARPI) stress, which persisted in castration-resistant prostate cancer (PCa), previously undefined in PCa.
    [Oncogene]

    Abstract

    A Machine Learning Framework Develops a DNA Replication Stress Model for Predicting Clinical Outcomes and Therapeutic Vulnerability in Primary Prostate Cancer

    Researchers designed a robust machine learning-based framework to comprehensively explore the impact of DNA replication stress on prognosis and treatment in five prostate cancer bulk transcriptomic cohorts with a total of 905 patients.
    [Journal of Translational Medicine]

    Full Article

    Ribosomal Protein L22-like1 Promotes Prostate Cancer Progression by Activating PI3K/Akt/mTOR Signaling Pathway

    The authors investigated the role of ribosomal protein L22-like1 in prostate cancer progression and the mechanisms involved.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    The ADAM9/WISP-1 Axis Cooperates with Osteoblasts to Stimulate Primary Prostate Tumor Growth and Metastasis

    Scientists elucidated how primary prostate cancer (PCa) cells cooperated with distal osteoblasts and contributed to the vicious cycle that led to metastatic PCa.
    [International Journal of Biological Sciences]

    AbstractFull ArticleGraphical Abstract

    Non-Pyrogenic Highly Pure Magnetosomes for Efficient Hyperthermia Treatment of Prostate Cancer

    Investigators reported the fabrication of highly pure magnetosomes that were synthesized by magnetotactic bacteria using pharmaceutically compatible growth media.
    [Applied Microbiology and Biotechnology]

    Abstract

    A Preoperative Magnetic Resonance Imaging-Based Model to Predict Biochemical Failure after Radical Prostatectomy

    Researchers investigated if a magnetic resonance imaging-based model reduced postoperative biochemical failure incidence in patients with prostate cancer.
    [Scientific Reports]

    Full Article

    Simultaneous Administration of EZH2 and BET Inhibitors Inhibits Proliferation and Clonogenic Ability of Metastatic Prostate Cancer Cells

    The authors tested, for the first time, the combination of an Enhancer of Zeste 2 (EZH2) inhibitor with a BET inhibitor in metastatic prostate cancer cells.
    [Journal of Enzyme Inhibition and Medicinal Chemistry]

    Full Article

    CoFe2O4 Spinel Ferrite Studies on Permanent Magnet Application and Cytotoxic Effects on Breast and Prostate Cancer Cell Lines

    The sol–gel auto-combustion preparation method using two different fuel agents, citric acid and glycine, was used to synthesize CoFe2O4 nanoparticles.
    [Journal of Materials Science: Materials in Electronics]

    Abstract
    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    REVIEWS

    Modelling AR Mutations

    A yeast reporter system enables a high-throughput study of the interaction between each ligand and androgen receptor (AR) mutant by visual observation of yeast colony formation and can be applied to high-throughput AR compound screening for the treatment of prostate cancer.
    [Nature Reviews Urology]

    Abstract
    INDUSTRY AND POLICY NEWS

    ​American Cancer Society Awards ASU Researcher $2.6 Million Grant to Continue Cancer Research

    Dr. Manoj Mishra has been awarded a four-year, $2,631,400 grant from the American Cancer Society’s Diversity in Cancer Research Institutional Development to continue Alabama State University’s cutting-edge cancer research program and outreach.
    [Alabama State University]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2023

    April 14 – 19, 2023
    Orlando, Florida, United States

    > See All Events

    JOB OPPORTUNITIES

    Group Leader – Cell Biology

    Pompeu Fabra University – Barcelona, Spain

    Research Scientist – Cancer Molecular Imaging

    Stanford Medicine – Stanford, California, United States

    PhD Positions – Life Sciences and Bioinformatics

    University Medical Center Freiburg – Freiburg, Germany

    Postdoctoral Scientist – Cancer Therapeutics

    UTHSC-Houston – Houston, Texas, United States

    Postdoc Research Associate – RNA Biology

    The University of British Columbia – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter